Home Compliance Novartis Faces Key Meeting in U.S. Bribery Scandal After Settling Corruption Case ComplianceNews Novartis Faces Key Meeting in U.S. Bribery Scandal After Settling Corruption Case July 6, 2020 32 Share FacebookLinkedinTwitter Christian Delbert | Shutterstock You must be a Paid or Free Trial Member to Access this Content. Paid members, please login to view your news subscription(s). RELATED ARTICLESMORE FROM AUTHOR Compliance Who Needs FEPA? Compliance Core FCPA Beliefs Compliance DOJ Seemingly Says – What The Heck, Let’s Try This Next